Acurx Pharmaceuticals, Inc. Proceeds from Common Stock Issued
Acurx Pharmaceuticals, Inc. (ACXP) had Proceeds from Common Stock Issued of $2.50 million as of 2026-04-15, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2026-08-13
- Acurx Pharmaceuticals, Inc. proceeds from issuance of common stock for the quarter ending 2022-12-31 was -$1.00.
- Acurx Pharmaceuticals, Inc. proceeds from issuance of common stock for fiscal 2022 was $3.70M.
| Period end | Proceeds from Issuance of Common Stock | Proceeds from Issuance of Common Stock as first filed | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|---|---|
| 2026-04-15 | $2.50M 10-Q · filed 2026-08-13 | |||||
| 2023-11-15 | $2.60M 10-K · filed 2024-03-15 | |||||
| 2023-06-30 | $3.54M 10-Q · filed 2023-08-11 | |||||
| 2023-05-18 | $4.00M 10-Q · filed 2026-08-13 | |||||
| 2023-05-16 | $4.00M 10-Q · filed 2024-11-12 | $3.50M 10-Q · filed 2023-08-11 | ||||
| 2022-12-31 | -$1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $3.70M 10-K · filed 2023-03-15 | ||||
| 2022-09-30 | $3.70M 10-Q · filed 2022-11-10 | |||||
| 2022-07-27 | $4.20M 10-Q · filed 2026-08-13 | |||||
| 2022-07-25 | $4.20M 10-Q · filed 2024-11-12 | $3.70M 10-K · filed 2023-03-15 | ||||
| 2021-06-29 | $17.30M 10-Q · filed 2026-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B |